Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2020-09-28 Conversion |
2020-09-30 4:39 pm |
N/A N/A |
Taysha Gene Therapies Inc. | TSHA | PRASAD SUYASH CMO and Head of R&D |
7,373 | $0 | 672,589 (Direct) |
View |
| 2020-09-28 Conversion |
2020-09-30 4:38 pm |
N/A N/A |
Taysha Gene Therapies Inc. | TSHA | Nolan Sean P. Director |
2,092,571 | $0 | 1,091,101 (Indirect) |
View |
| 2020-09-28 Conversion |
2020-09-30 4:37 pm |
N/A N/A |
Taysha Gene Therapies Inc. | TSHA | Nagendran Sukumar Director |
36,873 | $0 | 19,226 (Direct) |
View |
| 2020-09-28 Conversion |
2020-09-30 4:37 pm |
N/A N/A |
Taysha Gene Therapies Inc. | TSHA | Manning Paul B Director 10% Owner |
10,155,618 | $0 | 2,020,102 (Indirect) |
View |
| 2020-09-23 Option Award |
2020-09-25 5:14 pm |
N/A N/A |
Taysha Gene Therapies Inc. | TSHA | PRASAD SUYASH CMO and Head of R&D |
668,745 | $0 | 668,745 (Direct) |
View |
| 2020-09-23 Option Award |
2020-09-25 5:13 pm |
N/A 2030-09-23 |
Taysha Gene Therapies Inc. | TSHA | Nolan Sean P. Director |
31,000 | $0 | 31,000 (Direct) |
View |
| 2020-09-23 Option Award |
2020-09-25 5:12 pm |
N/A 2030-09-23 |
Taysha Gene Therapies Inc. | TSHA | Nagendran Sukumar Director |
31,000 | $0 | 31,000 (Direct) |
View |
| 2020-09-23 Option Award |
2020-09-25 5:11 pm |
N/A 2030-09-23 |
Taysha Gene Therapies Inc. | TSHA | Manning Paul B Director 10% Owner |
31,000 | $0 | 31,000 (Direct) |
View |
| 2020-09-23 Option Award |
2020-09-25 5:09 pm |
N/A 2030-09-23 |
Taysha Gene Therapies Inc. | TSHA | Donenberg Phillip B. Director |
31,000 | $0 | 31,000 (Direct) |
View |
| 2020-09-23 Option Award |
2020-09-25 5:08 pm |
N/A N/A |
Taysha Gene Therapies Inc. | TSHA | Alam Kamran Chief Financial Officer |
331,121 | $0 | 331,121 (Direct) |
View |
Ownership |
2020-09-23 8:32 pm |
N/A N/A |
Taysha Gene Therapies Inc. | TSHA | Session R.A. II President and CEO 10% Owner |
0 | $0 | 9,430,582 (Direct) |
View |
Ownership |
2020-09-23 8:30 pm |
N/A N/A |
Taysha Gene Therapies Inc. | TSHA | PRASAD SUYASH CMO and Head of R&D |
0 | $0 | 3,844 (Direct) |
View |
Ownership |
2020-09-23 8:29 pm |
N/A N/A |
Taysha Gene Therapies Inc. | TSHA | Nolan Sean P. Director |
0 | $0 | 1,091,101 (Indirect) |
View |
Ownership |
2020-09-23 8:28 pm |
N/A N/A |
Taysha Gene Therapies Inc. | TSHA | Nagendran Sukumar Director |
0 | $0 | 27,397 (Direct) |
View |
Ownership |
2020-09-23 8:27 pm |
N/A N/A |
Taysha Gene Therapies Inc. | TSHA | Manning Paul B Director 10% Owner |
0 | $0 | 5,295,307 (Indirect) |
View |
Ownership |
2020-09-23 8:25 pm |
N/A 2030-09-02 |
Taysha Gene Therapies Inc. | TSHA | Donenberg Phillip B. Director |
0 | $0 | 8,171 (Direct) |
View |